180 related articles for article (PubMed ID: 10946093)
21. The effects of additional carbohydrate in the coiled-coil region of fibrinogen on polymerization and clot structure and properties: characterization of the homozygous and heterozygous forms of fibrinogen Lima (Aalpha Arg141-->Ser with extra glycosylation).
Marchi R; Arocha-Piñango CL; Nagy H; Matsuda M; Weisel JW
J Thromb Haemost; 2004 Jun; 2(6):940-8. PubMed ID: 15140130
[TBL] [Abstract][Full Text] [Related]
22. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
Terasawa F; Kani S; Hongo M; Okumura N
Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498
[TBL] [Abstract][Full Text] [Related]
23. Fibrinogen αC domain: Its importance in physiopathology.
Soria J; Mirshahi S; Mirshahi SQ; Varin R; Pritchard LL; Soria C; Mirshahi M
Res Pract Thromb Haemost; 2019 Apr; 3(2):173-183. PubMed ID: 31011701
[TBL] [Abstract][Full Text] [Related]
24. [Importance of the structure of the clot in thrombolysis].
Soria C; Soria J; Mirshahi M; Desvignes P; Bonnet P; Caen JP
Ann Biol Clin (Paris); 1987; 45(2):207-11. PubMed ID: 2441630
[TBL] [Abstract][Full Text] [Related]
25. A novel natural mutation AαPhe98Ile in the fibrinogen coiled-coil affects fibrinogen function.
Riedelová-Reicheltová Z; Kotlín R; Suttnar J; Geierová V; Riedel T; Májek P; Dyr JE
Thromb Haemost; 2014 Jan; 111(1):79-87. PubMed ID: 24108601
[TBL] [Abstract][Full Text] [Related]
26. Sensing adhesion forces between erythrocytes and γ' fibrinogen, modulating fibrin clot architecture and function.
Guedes AF; Carvalho FA; Domingues MM; Macrae FL; McPherson HR; Santos NC; Ariёns RAS
Nanomedicine; 2018 Apr; 14(3):909-918. PubMed ID: 29410160
[TBL] [Abstract][Full Text] [Related]
27. Abnormal fibrinogen with an Aα 16Arg → Cys substitution is associated with multiple cerebral infarctions.
Luo M; Wei A; Xiang L; Yan J; Liao L; Deng X; Deng D; Cheng P; Lin F
J Thromb Thrombolysis; 2018 Oct; 46(3):409-419. PubMed ID: 29869737
[TBL] [Abstract][Full Text] [Related]
28. Two novel mutations in the fibrinogen γ nodule.
Kotlín R; Pastva O; Stikarová J; Hlaváčková A; Suttnar J; Chrastinová L; Riedel T; Salaj P; Dyr JE
Thromb Res; 2014 Oct; 134(4):901-8. PubMed ID: 25074738
[TBL] [Abstract][Full Text] [Related]
29. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.
Haverkate F; Samama M
Thromb Haemost; 1995 Jan; 73(1):151-61. PubMed ID: 7740487
[TBL] [Abstract][Full Text] [Related]
30. Fibrinogenemia Tampere--a dysfibrinogenemia with defective gelation and thromboembolic disease.
Hessel B; Silveira AM; Carlsson K; Oksa H; Rasi V; Vahtera E; Procyk R; Blombäck B
Thromb Res; 1995 May; 78(4):323-39. PubMed ID: 7631313
[TBL] [Abstract][Full Text] [Related]
31. Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function.
Undas A; Zdziarska J; Iwaniec T; Stepien E; Skotnicki AB; de Moerloose P; Neerman-Arbez M
Thromb Haemost; 2009 May; 101(5):975-6. PubMed ID: 19404553
[No Abstract] [Full Text] [Related]
32. Dysfibrinogenemia and thrombosis.
Soria J; Soria C; Collet JP; Mirishahi M; Lu H; Caen JP
Nouv Rev Fr Hematol (1978); 1991; 33(6):457-9. PubMed ID: 1818298
[TBL] [Abstract][Full Text] [Related]
33. Fibrinogen Dusart: electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots.
Collet JP; Woodhead JL; Soria J; Soria C; Mirshahi M; Caen JP; Weisel JW
Biophys J; 1996 Jan; 70(1):500-10. PubMed ID: 8770228
[TBL] [Abstract][Full Text] [Related]
34. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II).
Kamijyo Y; Hirota-Kawadobora M; Yamauchi K; Terasawa F; Honda T; Ikeya M; Okumura N
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):726-32. PubMed ID: 19809304
[TBL] [Abstract][Full Text] [Related]
35. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management.
Casini A; Neerman-Arbez M; Ariëns RA; de Moerloose P
J Thromb Haemost; 2015 Jun; 13(6):909-19. PubMed ID: 25816717
[TBL] [Abstract][Full Text] [Related]
36. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).
Mosesson MW; Siebenlist KR; DiOrio JP; Matsuda M; Hainfeld JF; Wall JS
J Clin Invest; 1995 Aug; 96(2):1053-8. PubMed ID: 7635941
[TBL] [Abstract][Full Text] [Related]
37. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE
Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725
[TBL] [Abstract][Full Text] [Related]
38. BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
Greenhalgh KA; Strachan MW; Alzahrani S; Baxter PD; Standeven KF; Storey RF; Ariens RA; Grant PJ; Price JF; Ajjan RA
Thromb Haemost; 2017 Jan; 117(2):295-302. PubMed ID: 27929198
[TBL] [Abstract][Full Text] [Related]
39. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
[TBL] [Abstract][Full Text] [Related]
40. Evidence that fibrinogen γ' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness.
Allan P; Uitte de Willige S; Abou-Saleh RH; Connell SD; Ariëns RA
J Thromb Haemost; 2012 Jun; 10(6):1072-80. PubMed ID: 22463367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]